What is ulcerative colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory bowel disease characterized by continuous mucosal inflammation that begins in the rectum and extends proximally through the colon in a confluent pattern, presenting classically with bloody diarrhea. 1

Disease Definition and Pathophysiology

Ulcerative colitis is a chronic idiopathic inflammatory disorder limited to the colonic mucosa, resulting from dysregulated immune responses to intraluminal antigens in genetically susceptible individuals. 1, 2 The inflammation is superficial, affecting only the mucosal layer (unlike Crohn's disease which is transmural), and characteristically starts at the anal verge and extends proximally in a continuous, confluent fashion with clear demarcation between inflamed and normal areas. 1

The etiology remains unknown, but represents a response to environmental triggers (infection, drugs, or other agents) in genetically predisposed individuals. 1 Smoking paradoxically decreases the risk of UC (unlike Crohn's disease where it increases risk). 1

Cardinal Clinical Features

The cardinal symptom of UC is bloody diarrhea. 1 Associated symptoms include:

  • Colicky abdominal pain 1
  • Rectal urgency and tenesmus 1, 2
  • Mucus in stool 2
  • Fecal incontinence 3
  • Nocturnal diarrhea 3

Systemic symptoms are less common than in Crohn's disease but may include fever, weight loss, malaise, and fatigue. 1, 3

Disease Extent Classification

UC is classified by anatomic extent using the Montreal classification: 1, 4

  • E1 (Proctitis): Limited to the rectum
  • E2 (Left-sided colitis): Extends to the splenic flexure
  • E3 (Extensive colitis): Extends proximal to the splenic flexure
  • E4 (Pancolitis): Extends proximal to the hepatic flexure, affecting the entire colon 4

Pancolitis affects 20-40% of UC patients and carries the highest 10-year colectomy rate at 19% and the greatest colorectal cancer risk. 4

Diagnostic Approach

A gold standard for UC diagnosis does not exist—it requires the combination of clinical presentation, endoscopic findings with histopathology, and exclusion of infectious causes. 1

Endoscopic Features

The diagnosis requires sigmoidoscopy or colonoscopy demonstrating continuous, confluent inflammation starting at the anal verge with: 1

  • Loss of normal vascular pattern
  • Granularity and erythema
  • Mucosal friability
  • Spontaneous bleeding
  • Erosions and ulcerations in severe cases

Histopathological Confirmation

Biopsies from at least five sites around the colon (including rectum) and ileum are required. 1 Key microscopic features include: 1

  • Basal plasmacytosis (earliest diagnostic feature with highest predictive value) 1
  • Crypt architectural distortion and decreased crypt density
  • Diffuse transmucosal inflammatory infiltrate
  • Cryptitis and crypt abscesses
  • Absence of granulomas (which suggest Crohn's disease)

Essential Investigations

Initial workup must include: 1

  • Full blood count (may show anemia, thrombocytosis, or leucocytosis)
  • C-reactive protein and ESR
  • Electrolytes, liver and renal function
  • Fecal calprotectin
  • Stool cultures to exclude infectious pathogens, specifically C. difficile toxin 1
  • Immunization status assessment 3

Disease Course and Prognosis

UC follows a relapsing-remitting course, with approximately 50% of patients experiencing a relapse in any given year. 1 The disease carries: 1, 5

  • Slight excess mortality in the first two years after diagnosis
  • 20-30% of pancolitis patients ultimately require colectomy
  • 4.5% risk of colorectal cancer after 20 years of disease duration
  • 1.7-fold higher colorectal cancer risk compared to general population 5
  • Life expectancy approximately 5 years shorter than people without UC 5

Approximately 20% of patients experience acute severe UC requiring hospitalization during their disease course, which remains a potentially life-threatening condition. 1, 6

Extraintestinal Manifestations

Approximately 27% of UC patients develop extraintestinal manifestations, including: 3, 5

  • Inflammatory arthropathies
  • Primary sclerosing cholangitis (most clinically important)
  • Skin lesions (erythema nodosum, pyoderma gangrenosum)
  • Eye inflammation (uveitis, episcleritis)

Critical Pitfalls

Always exclude infectious causes, particularly C. difficile and Cytomegalovirus, during disease flares, as these can mimic or exacerbate UC. 3 Testing should be repeated with every flare. 1

The macroscopic extent at colonoscopy may underestimate true disease extent compared with histology—biopsies are essential for accurate risk stratification for dysplasia surveillance. 4 Classification should always reflect the maximal extent ever documented, even if inflammation regresses with treatment. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Comprehensive Approach to Ulcerative Colitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Panulcerative Colitis Definition and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute severe ulcerative colitis: from pathophysiology to clinical management.

Nature reviews. Gastroenterology & hepatology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.